Optimization of extraction parameters for the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets

Forensic Science International

Volumn 132, Issue 3, 2003, Pages 182-194

  Gimeno, Pascal ^a   Besacier, Fabrice ^a   Chaudron Thozet, Huguette ^a  

^a Centre Universitaire des Saints Pères   (France)

Author keywords

3,4 Methylenedioxymethamphetamine (MDMA); Gas chromatography; Impurities; Mass spectrometry; Profiling

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ETHER;

ARTICLE; DRUG IMPURITY; DRUG MONITORING; DRUG STORAGE; EVAPORATION; FOLLOW UP; GAS CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; MEDICOLEGAL ASPECT; PH; PRIORITY JOURNAL; SAMPLING; SOLID PHASE EXTRACTION; STANDARDIZATION; TABLET FORMULATION;

EID: 0037426475     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(03)00019-7     Document Type: Article

References (18)

1. Anon., European Union situation report on drug production and drug trafficking 2000-01, Europol, Hague, 2001.
2. Gimeno P., Besacier F., Chaudron-Thozet H., Girard J., Lamotte A. A contribution to the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets. Forensic Sci. Int. 127:2002;1-44.
3. Sten C., Jonson L., Artizzu N. Factors influencing the extraction of impurities from Leuckart amphetamine. Forensic Sci. Int. 93:1998;99-116.
4. Renton R.J., Cowie J.S., Oon M.C.H. A study of the precursors 3,4-methyenedioxymethylamphetamine and its application to forensic drug analysis. Forensic Sci. Int. 60:1993;189-202.
5. E. Lock, Impurities found in MDMA and MDEA street samples: synthesis, identification and interpretation, in: Proceedings of the ENFSI First European Meeting of Forensic Science, Lausanne, Switzerland, 17-19 September 1997.
6. Bohn M., Bohn G., Blaschke G. Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine. Int. J. Legal Med. 106:1993;19-23.
7. Rashed A.M., Anderson R.A., King L.A.et al. Solid-phase extraction for profiling of ecstasy tablets. J. Forensic Sci. 45:2000;413-417.
8. Stein D. The use of heliotrope oil as a precursor source for piperonal. J. Clan. Lab. Invest. Chem. 6:1996;17-18.
9. Drug Enforcement Administration, Uncommon precursor sources used in 3,4-methylenedioxymethamphetamine (MDMA), Microgram 32 (1999) 193-194.
10. Poortman A. Unusual manufacturing of MDMA in The Netherlands. J. Clan. Lab. Invest. Chem. 8:1998;25-26.
11. Laing R.R., Dawson B. Identification of the major product from the Ritter reaction using safrole. J. Clan. Lab. Invest. Chem. 7:1997;22-26.
12. Dal Carson T.A. An evaluation of the potential for clandestine manufacture of 3,4-methylenedioxyamphetamine (MDA) analogs and homologs. J. Forensic Sci. 34:1990;675-697.
13. Randall Clark C., Taylor Noggle F., DeRuiter J. GC-MS analysis of products, intermediates and by-products in the synthesis of MDA from isosafrole. Microgram. 27:1994;188-200.
14. Lukaszewski T. Spectroscopic and chromatographic identification of precursors, intermediates, and impurities of 3,4-methylenedioxyamphetamine synthesis. J. Assoc. Off. Anal. Chem. 61:1978;951-967.
15. Noggle F.T., Randall Clarck C., Deruiter J. Gas chromatographic and mass spectrometric analysis of samples from clandestine laboratory involved in the synthesis of ecstasy from sassafras oil. J. Chromatogr. Sci. 29:1991;168-173.
16. Verweij A.M.A. Clandestine manufacture of 3,4-methylenedioxymethamphetamine (MDMA) by low pressure reductive amination. A mass spectrometric study of some reaction mixtures. Forensic Sci. Int. 45:1990;91-96.
17. Verweij A.M.A. Impurities in illicit drug preparation (XXIV). Spectroscopic properties of some compounds present in essential oils, used as starting compounds in the synthesis of "designer drugs" of the phenethylamine type. Microgram. 28:1995;224-228.
18. Verweij A.M.A. Impurities in illicit drug preparations: 3,4-(methylenedioxy)amphetamine and 3,4-(methylenedioxy)methylamphetamine. Forensic Sci. Rev. 4:1992;137-146.